Secondary prevention and referral of elderly patients to a cardiovascular lipid service

Archives of Gerontology and Geriatrics

Volumn 29, Issue 1, 1999, Pages 1-11

  Nawawi, Hapizah ^a   Day, Lorna ^a   Mikhailis, Dimitri ^a   Hamilton, George ^b   Winder, Anthony ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Fibrinogen; Health services for the aged; Ischaemic heart disease; Lipoprotein(a); Lipoproteins; Peripheral vascular disease

Indexed keywords

CHOLESTEROL; FIBRINOGEN; LIPID; LIPOPROTEIN; LIPOPROTEIN A; TRIACYLGLYCEROL;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; GENERAL PRACTICE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; OBESITY; PATIENT REFERRAL; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE;

EID: 0032785209     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(99)00014-X     Document Type: Article

References (40)

1. Ballou S.P., Lozanski F.B., Hodder S., Rzewnicki D.L., Mion L.C., Sipe J.D., Ford A.B., Kushner I. Quantitative and qualitative alterations of acute phase proteins in healthy elderly subjects. Age Ageing. 25:1996;224-230.
2. Barrett-Connor E. Hypercholesterolaemia predicts early death from coronary heart disease in elderly men not women: the Rancho Bernado study. Ann. Epidemiol. 2:1992;77-83.
3. Benefante R., Reed D. Is elevated serum cholesterol a risk factor for coronary heart disease in the elderly? J. Am. Med. Assoc. 253:1990;393-396.
4. Berg K., Ro O.C. Lp(a) lipoprotein level and longevity. Ann. Genet. 34:1991;264-269.
5. Butowski P.F., Winder A.F. Changing patterns of referral to UK lipid clinics - a ten year perspective. Eur. J. Med. Res. 3:1998;502-507.
6. Butowski P.F., Winder A.F. Usual care dietary practice, achievement and implications for medication in the management of hypercholesterolaemia: data from the UK Lipid Clinics programme. Eur. Heart J. 19:1998;1328-1333.
7. Chan P., Tomlinson B., Lee C.B., Pan W.H., Lee Y.S. Beneficial effects of pravastatin on fasting hyperinsulinaemia in elderly hypertensive hypercholesterolaemic subjects. Hypertension. 28:1996;647-651.
8. Chew C.A., Wilkin D., Glendinning C. Annual assessments of patients aged 75 years and over: views and experiences of elderly people. Br. J. Gen. Pract. 44:1994;567-570.
9. D'Agostino R.B., Kannel W.B., Stepanians M.N., D'Agostino L.C. Efficacy and tolerability of lovastatin in elderly hypercholesterolaemic patients. Clin. Ther. 14:1992;68-76.
10. Denke M.A., Grundy S.M. Hypercholesterolaemia in elderly persons: resolving the treatment dilemma. Ann. Intern. Med. 112:1990;780-792.
11. Ernst E., Resch K.L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann. Intern. Med. 118:1993;956-963.
12. Evans P., Pereira Grey D. Value of screening for secondary causes of hyperlipidaemia in general practice. Br. Med. J. 309:1994;509-510.
13. Ferrara A., Barrett-Connor E., Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernado Study 1984-1994. Circulation. 96:1997;37-43.
14. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein in plasma without use of the ultracentrifuge. Clin. Chem. 18:1972;499-502.
15. Garber A.M., Littenberg B., Sox H.C., Wagner J.L., Gluck M. Costs and health consequences of cholesterol screening for asymptomatic older Americans. Ann. Intern. Med. 151:1991;1089-1095.
16. Kannel W.B., Wolf P.A., Castelli W.P., D'Agostino R.B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. J. Am. Med. Assoc. 258:1987;1183-1186.
17. Kligman E.W., Watkins A.J. Screening for coronary heart disease risk in the elderly: total cholesterol versus high-density lipoprotein-cholesterol. Am. J. Prevent. Med. 7:1991;263-267.
18. Laharrague P.F., Cambus J.P., Fillola G., Corberand J.X. Plasma fibrinogen and physiological aging. Aging. 5:1993;445-449.
19. La Rosa J.C., Applegate W., Crouse J.R. III, Hunninghake D.B., Grimm R., Knopp R., Eckfeldt J.H., Davis C.E., Gordon D.J. Cholesterol lowering in the elderly. Results of the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study. Arch. Intern. Med. 154:1994;529-539.
20. Lewis S.J., Moye L.A., Sacks F.M., Johnstone D.E., Timmis G., Mitchell J., Limacher M., Kell S., Glasser S.P., Grant J., Davis B.R., Pfeffer M.A., Braunwald E. Effect of pravastatin in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) Trial. Ann. Intern. Med. 129:1998;681-689.
21. LIPID Study Group, 1998. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New Engl. J. Med. 339, 1349-1357.
22. Mbewu A.D., Bhatnagar D., Durrington P.N., Hunt L., Ishola M., Arrol S., Mackness M., Lockley P., Miller J.P. Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolaemia, their relatives, and unrelated control populations. Arter. Thromb. 11:1991;940-946.
23. Mellies M.J., De Vault A.R., Kassler T.K., McGovern M.E., Pan H.Y. Pravastatin experience in elderly and non-elderly patients. Atherosclerosis. 101:1993;97-110.
24. Miettinen T.A., Pyorala K., Olsson A.G., Musliner T.A., Cook T.J., Faergeman O., Berg K., Pedersen T., Kjekshus J. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Findings from the Scandinavian Simvastatin Survival Study (4S). Circulation. 96:1997;4211-4218.
25. Mikhailidis D.P., Ganotakis E.S., Spyropoulos K.A., Jagroop I.A., Byrne D.J., Winder A.F. Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice. Int. Angiol. 17:1998;225-233.
26. Pacala J.T., Mc Bride P.E., Gray S.L. Management of older adults with hypercholesterolaemia. Drugs Ageing. 4:1994;366-378.
27. Papadakis J.A., Mikhailidis D.P., Winder A.F. Lipids and stroke: neglect of a useful preventive measure? Cardiovasc. Res. 40:1998;265-271.
28. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., Macfarlane P.W., McKillop J.H., Packard C.J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. New Engl. J. Med. 333:1995;1301-1307.
29. Simons L.A., Friedlander Y., Simons J., McCallum J. Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional study from the Dubbo study. Atherosclerosis. 99:1993;87-95.
30. Stamler J. Risk modification trials: implication for the elderly. Eur. Heart J. 9:1988;9-53.
31. Stober C., Clarke A., Mulvaney A., Harland J., Nethercut W.D. Cholesterol and lipoprotein(a) as risk factors for coronary heart disease in elderly subjects. Br. J. Biomed. Sci. 51:1994;114-118.
32. Stout R.W., Crawford V.L., McDermott M.J., Rocks M.J., Morris T.C. Seasonal changes in haemostatic factors in young and elderly subjects. Age Ageing. 25:1996;256-258.
33. Sutton-Tyrrel K., Evans R.W., Meilahn E., Alcorn H.G. Lipoprotein(a) and peripheral atherosclerosis in older adults. Atherosclerosis. 122:1996;11-19.
34. Tervahauta M., Pekkanen J., Kivinen P., Stengard J., Jauhiainen M., Ehnholm C., Nissinen A. Prevalence of coronary heart disease and associated risk factors among elderly Finnish men in the Seven Countries study. Atherosclerosis. 104:1993;47-59.
35. Tresch D.D., Aronow W.S. Clinical manifestations and diagnosis of coronary artery disease. Clin. Geriatr. Med. 12:1996;89-100.
36. Walker A.R., Walker B.F., Manetsi B., Molefe O., Walker A.J., Voster H.H. Obesity in indigent rural African women: effects on hypertension, hyperlipidaemia and hyperglycaemia. Int. J. Vitam. Nutr. Res. 61:1991;244-250.
37. Weverling-Rijnsberger A.W.E., Blauw G., Lagaay A.M., Knook D., Meinders A.E. Total cholesterol and risk of mortality in the oldest old. Lancet. 350:1997;1119-1123.
38. WHO, 1980. World Health Organisation Expert Committee on Diabetes Mellitus, Second report. WHO Tech. Rep. Ser. 646. WHO, Geneva, pp. 7-42.
39. Winder A.F. Management of lipids in the elderly. J. R. Soc. Med. 91:1998;189-191.
40. Winder A.F., Jagger C., Garrick D.P., Vallance D.T., Butowski P.F., Anderson J., Clarke M. Lipid screening in an elderly population: difficulty in interpretation and in the detection of occult metabolic disease. J. Clin. Pathol. 49:1996;278-283.